|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 102.1 GBX | -0.85% |
|
-0.85% | +17.38% |
| Apr. 02 | Roadside shares suspended; Adnams looks for funds | AN |
| Mar. 21 | Diaceutics upgrades diagnositc commercialisation platform, DXRX | AN |
Diaceutics PLC reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was GBP 13.94 million compared to GBP 12.7 million a year ago. Net income was GBP 0.561 million compared to GBP 0.263 million a year ago.
Basic earnings per share from continuing operations was GBP 0.0067 compared to GBP 0.0034 a year ago. Diluted earnings per share from continuing operations was GBP 0.0066 compared to GBP 0.0034 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +17.38% | 108M | |
| +5.43% | 4.04B | |
| 0.00% | 2.19B | |
| +22.70% | 1.91B | |
| -2.71% | 1.72B | |
| -18.54% | 1.55B | |
| -23.86% | 1.38B | |
| -9.89% | 1.14B | |
| -5.48% | 1.04B | |
| +119.33% | 694M |
DIACEUTICS PLC 
